KR880701555A - 소염제 크림 조성물 - Google Patents

소염제 크림 조성물

Info

Publication number
KR880701555A
KR880701555A KR1019880700606A KR880700606A KR880701555A KR 880701555 A KR880701555 A KR 880701555A KR 1019880700606 A KR1019880700606 A KR 1019880700606A KR 880700606 A KR880700606 A KR 880700606A KR 880701555 A KR880701555 A KR 880701555A
Authority
KR
South Korea
Prior art keywords
alpha
cream composition
inflammatory cream
inflammatory
furoate
Prior art date
Application number
KR1019880700606A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR880701555A publication Critical patent/KR880701555A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Semiconductor Memories (AREA)
  • Insulated Gate Type Field-Effect Transistor (AREA)
  • Cosmetics (AREA)
KR1019880700606A 1986-10-02 1988-05-30 소염제 크림 조성물 KR880701555A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/914,227 US4808610A (en) 1986-10-02 1986-10-02 Mometasone furoate anti-inflammatory cream composition using hexylene glycol
PCT/US1987/002470 WO1988002257A1 (en) 1986-10-02 1987-10-01 Anti-inflammatory cream composition

Publications (1)

Publication Number Publication Date
KR880701555A true KR880701555A (ko) 1988-11-03

Family

ID=25434063

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019880700606A KR930010585B1 (ko) 1986-10-02 1987-10-01 소염제 크림 조성물
KR1019880700606A KR880701555A (ko) 1986-10-02 1988-05-30 소염제 크림 조성물

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1019880700606A KR930010585B1 (ko) 1986-10-02 1987-10-01 소염제 크림 조성물

Country Status (22)

Country Link
US (1) US4808610A (ko)
EP (2) EP0318522A1 (ko)
JP (1) JPH0643317B2 (ko)
KR (2) KR930010585B1 (ko)
AT (1) ATE62815T1 (ko)
AU (1) AU603837B2 (ko)
CA (1) CA1294877C (ko)
DE (1) DE3769568D1 (ko)
DK (1) DK174790B1 (ko)
ES (1) ES2038643T3 (ko)
FI (1) FI100047B (ko)
GR (1) GR3002086T3 (ko)
HK (1) HK102593A (ko)
IE (1) IE60492B1 (ko)
IL (1) IL84055A (ko)
MX (1) MX9203395A (ko)
NO (1) NO175350C (ko)
NZ (1) NZ222020A (ko)
OA (1) OA09034A (ko)
PH (1) PH23440A (ko)
WO (1) WO1988002257A1 (ko)
ZA (1) ZA877401B (ko)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108994T1 (de) * 1987-09-23 1994-08-15 Oreal Hautbehandlungsmittel als aerosolschaum, das vaseline enthält.
US5223340A (en) * 1989-04-20 1993-06-29 Peach State Labs, Inc. Stain resistant polyamide fibers
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
PL165803B1 (pl) * 1990-09-10 1995-02-28 Schering Corp Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL
US6127353A (en) * 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US5407678A (en) * 1993-09-01 1995-04-18 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Petroleum jelly cream
NZ278198A (en) * 1993-12-21 1997-12-19 Schering Corp Pharmaceutical compositions comprising mometasone furoate and salicyclic acid; use in treatment of psoriasis
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
AU5303899A (en) * 1998-08-26 2000-03-21 Shionogi & Co., Ltd. Anti-inflammatory ointments
FR2787025B1 (fr) * 1998-12-14 2002-10-11 Oreal Composition sous forme d'emulsion h/e a forte teneur en cire et ses utilisations dans les domaines cosmetique et dermatologique
EP1478031A4 (en) 2002-02-19 2008-12-03 Hoya Corp LIGHT EMISSION ELEMENT OF THE FIELD EFFECT TRANSISTOR TYPE
CA2532707A1 (en) 2003-05-23 2004-12-09 Taro Pharmaceuticals U.S.A., Inc. Novel topical steroid cream formulations
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2120868A4 (en) * 2007-04-11 2010-08-25 Perrigo Israel Phamaceuticals LOW-DOSED MOMETASON FORMULATIONS
US20080311058A1 (en) * 2007-06-18 2008-12-18 Connopco, Inc., D/B/A Unilever Stable high internal phase emulsions and compositions comprising the same
RU2470645C2 (ru) * 2007-09-10 2012-12-27 Гленмарк Фармасьютикалс Лимитед Фармацевтическая композиция для местного применения, содержащая комбинацию фузидовой кислоты и кортикостероида
US20090082318A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched mometasone
AU2009310634B2 (en) * 2008-10-30 2013-05-09 Ego Pharmaceuticals Pty Ltd Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
PT2429510E (pt) 2009-05-12 2015-10-12 Galenica Ab Emulsão de óleo em água de mometasona e propilenglicol
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate
US20110305649A1 (en) * 2010-06-14 2011-12-15 Conopco, Inc., D/B/A Unilever High Humectant High Internal Phase Emulsion
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
US8398959B2 (en) 2010-12-06 2013-03-19 Conopco, Inc. Compositions and methods for imparting a sunless tan with functionalized adjuvants
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
RU2548764C2 (ru) * 2013-01-25 2015-04-20 Открытое Акционерное Общество "Татхимфармпрепараты" Лекарственное средство для лечения дерматозов (варианты)
US9744122B2 (en) * 2013-04-29 2017-08-29 Helene Bertrand Topical formulation for pain relief
JP2015196663A (ja) * 2014-04-01 2015-11-09 ロレアル ナノ又はマイクロエマルションの形態の組成物
FR3039399B1 (fr) * 2015-07-31 2018-08-24 Idl International Drug Licensing Creme pour l'admnistration de steroides et son procede de preparation
BR112023002533A2 (pt) * 2020-08-20 2023-03-14 Pfizer Formulações tópicas estáveis de 1(r)-4-(5-(4-metóxi-3-propoxifenil)piridin-3-il)-1,2-oxaborolan-2-ol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048310A (en) * 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
US4124707A (en) * 1976-12-22 1978-11-07 Schering Corporation 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
US4201778A (en) * 1977-11-08 1980-05-06 Schering Corporation 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates
US4267173A (en) * 1979-11-05 1981-05-12 Schering Corporation Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
JPS59137408A (ja) * 1983-01-27 1984-08-07 Taisho Pharmaceut Co Ltd 軟膏
US4489071A (en) * 1983-12-09 1984-12-18 Schering Corporation Betamethasone dipropionate cream

Also Published As

Publication number Publication date
KR930010585B1 (ko) 1993-10-30
ES2038643T3 (es) 1993-08-01
PH23440A (en) 1989-08-07
AU603837B2 (en) 1990-11-29
NZ222020A (en) 1990-03-27
GR3002086T3 (en) 1992-12-30
NO882417L (no) 1988-06-01
WO1988002257A1 (en) 1988-04-07
EP0262681A1 (en) 1988-04-06
DK295088D0 (da) 1988-05-31
DK295088A (da) 1988-05-31
AU8071287A (en) 1988-04-21
US4808610A (en) 1989-02-28
IL84055A (en) 1991-09-16
NO175350C (no) 1994-10-05
FI100047B (fi) 1997-09-15
JPH0643317B2 (ja) 1994-06-08
ZA877401B (en) 1988-05-25
IL84055A0 (en) 1988-03-31
NO882417D0 (no) 1988-06-01
EP0318522A1 (en) 1989-06-07
JPH02500976A (ja) 1990-04-05
MX9203395A (es) 1992-07-01
OA09034A (en) 1991-03-31
ATE62815T1 (de) 1991-05-15
DK174790B1 (da) 2003-11-17
HK102593A (en) 1993-10-08
FI891552A0 (fi) 1989-03-31
NO175350B (no) 1994-06-27
FI891552A (fi) 1989-03-31
IE872633L (en) 1988-04-02
CA1294877C (en) 1992-01-28
DE3769568D1 (de) 1991-05-29
IE60492B1 (en) 1994-07-27
EP0262681B1 (en) 1991-04-24

Similar Documents

Publication Publication Date Title
KR880701555A (ko) 소염제 크림 조성물
DE2965284D1 (en) Pharmaceutical compositions for topical administration containing prostaglandins
EG17753A (en) Novel pharmacological compounds
DK581185D0 (da) Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre
ZA791732B (en) Carbazolyl-(4)-oxypropanolamine derivatives,preparation thereof and pharmaceutical compositions containing these compounds
MY101784A (en) Novel pharmacological compounds
IT8221278A0 (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
SE8600658D0 (sv) Novel composition of matter
DE3873232T2 (de) Ein dideoxynukleosid enthaltendes arzneimittel.
PH27567A (en) Topical compositions
DE3273193D1 (en) Cream base
MX9204815A (es) Hexahidrobenzo[f]quinolinonas y formulacion farmaceutica que las comprende.
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
AU1646983A (en) Corticoid formulations
NZ189211A (en) 1,4-cyclohexadiene carboxylic acid derivatives and pharmaceutical compositions
SE7902817L (sv) Substituerade /4h/ 1,3-bensodioxin-2-karboxylsyraderivat, framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa
IT1201431B (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10 triacetossi-1,8,9 antracene
IT7920770A0 (it) Composizioni dermatologiche a basedi derivati dell'acido mercaptopropionammido-acetico.
IT7823614A0 (it) Composizioni farmaceutiche contenenti derivati dell'acido mercapto-acetico.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20071001

Year of fee payment: 15

EXPY Expiration of term